Watchlist Price Alert

Enfusion Inc. (ENFN)

NYSE: ENFN · Real-Time Price · USD

10.76

-0.04 (-0.37%)

At close: Apr 17, 2025, 3:59 PM

Enfusion Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	201.61M	195.16M	188.35M	181.62M	174.53M	168.57M	163.36M	157.18M	150.35M	141.69M	131.58M	121.49M	111.7M	102.51M	93.25M	85.36M	79.56M	56.91M	37.12M	18.56M
Cost of Revenue	64.87M	64.1M	62.27M	60.51M	57.64M	55.31M	52.78M	49.42M	47.1M	43.97M	40.09M	36.02M	31.84M	27.84M	25.14M	23.26M	21.36M	15.2M	9.81M	4.9M
Gross Profit	136.74M	131.06M	126.08M	121.1M	116.89M	113.25M	110.58M	107.76M	103.25M	97.72M	91.49M	85.47M	79.86M	74.67M	68.11M	62.09M	58.21M	41.7M	27.31M	13.66M
Operating Income	6.16M	6.71M	6.41M	6.16M	11.95M	11.19M	11.44M	5.09M	-11.96M	-305.83M	-303.87M	-294.06M	-275.88M	4.7M	5.96M	5.97M	6.07M	18M	11.82M	5.91M
Interest Income	1.69M	2.8M	2.31M	2.42M	2.6M	1.38M	1.38M	916K	424K	n/a	n/a	n/a	n/a	n/a	n/a	364K	728K	728K	728K	364K
Pretax Income	7.39M	7.11M	7.28M	5.52M	11.48M	10.51M	10.37M	5.28M	-12.19M	-307.41M	-306.85M	-298.45M	-281.66M	-52K	2.31M	3.36M	4.49M	16.9M	11.1M	5.55M
Net Income	2.82M	3.33M	3.74M	2.54M	7.77M	7.94M	8.71M	5.66M	-11.56M	-306.24M	-305.55M	-298.87M	-282.24M	-534K	1.75M	2.84M	4.06M	16.25M	10.67M	5.33M
Selling & General & Admin	103.86M	98.8M	96.03M	92.93M	85.05M	83.46M	81.61M	85.88M	98.05M	244.61M	237.68M	223.53M	202.34M	61.33M	54.46M	49.05M	45.81M	19.19M	12.61M	6.31M
Research & Development	26.73M	25.55M	23.64M	22.01M	19.89M	18.61M	17.53M	16.79M	17.16M	158.94M	157.68M	156M	153.4M	8.64M	7.68M	7.08M	6.32M	4.52M	2.88M	1.44M
Other Expenses	-193K	-1.87M	-1.45M	-2.6M	-2.1M	-1.02M	-1.49M	-230K	-638K	-1.26M	-1.18M	-1.18M	-1.19M	110K	81K	81K	81K	n/a	n/a	n/a
Operating Expenses	130.58M	124.35M	119.67M	114.95M	104.95M	102.07M	99.14M	102.67M	115.21M	403.55M	395.36M	379.52M	355.74M	69.97M	62.15M	56.13M	52.13M	23.71M	15.49M	7.74M
Interest Expense	n/a	303K	303K	303K	1.64M	1.76M	1.77M	1.77M	435K	318K	1.8M	3.21M	4.59M	4.86M	3.74M	2.33M	935K	365K	n/a	n/a
Selling & Marketing Expenses	25.03M	24.01M	23.29M	22.55M	20.42M	20.87M	22.64M	24.94M	29.29M	62.69M	60.31M	57M	51.73M	15.63M	12.8M	10.81M	9.93M	6.62M	4.55M	2.27M
Cost & Expenses	195.46M	188.45M	181.94M	175.46M	162.59M	157.38M	151.92M	152.09M	162.31M	447.52M	435.45M	415.54M	387.58M	97.81M	87.28M	79.39M	73.49M	38.91M	25.3M	12.65M
Income Tax Expense	3.52M	2.47M	1.93M	1.72M	2.23M	1.37M	1.29M	1.32M	1.07M	531K	398K	428K	580K	482K	556K	521.5K	434K	657K	429K	214.5K
Shares Outstanding (Basic)	94.26M	92.9M	92.38M	89.51M	88.28M	87.74M	88.31M	88.86M	88.02M	131.76M	84.58M	79.81M	83.17M	64.07M	64.07M	64.07M	64.07M	64.07M	64.07M	88.56M
Shares Outstanding (Diluted)	129.56M	128.98M	128.85M	89.51M	127.77M	127.84M	129.86M	132.35M	132.95M	131.76M	84.58M	83.38M	83.17M	64.07M	64.07M	64.07M	64.07M	64.07M	64.07M	88.56M
EPS (Basic)	0.04	0.04	0.04	0.03	0.09	0.09	0.09	0.05	-0.16	-3.7	-3.67	-3.57	-3.35	-0.01	0.03	0.04	0.04	0.23	0.14	0.06
EPS (Diluted)	0.02	0.03	0.03	0.02	0.06	0.06	0.07	0.03	-0.15	-3.69	-3.66	-3.56	-3.35	-0.01	0.03	0.04	0.04	0.23	0.14	0.06
EBITDA	14.54M	17.61M	14.47M	12.63M	15.74M	13.46M	15.41M	9.39M	-6.32M	-301.08M	-300.81M	-291.7M	-274.11M	7.12M	8.82M	8.25M	7.95M	19.12M	12.51M	6.25M
EBIT	6.16M	6.67M	6.72M	5.2M	11.41M	10.68M	10.59M	5.5M	-11.96M	-307.05M	-305.09M	-295.27M	-277.1M	4.78M	6.05M	6.05M	6.16M	18M	11.82M	5.91M
Depreciation & Amortization	8.51M	10.62M	12.16M	14.66M	13.82M	13.65M	10.85M	7.09M	6.6M	5.97M	5.26M	4.56M	3.98M	3.33M	3.6M	3.03M	2.62M	1.95M	686K	343K